InvestorRelations
Please contact us for any investor information using the form below.
CurrentNews
EmpowerPharm, independent research report by Crystal Research Associates
November 18, 2024
EmpowerPharm Inc. (“EmpowerPharm” or “the Company”) is a Canadian pharmaceutical company dedicated to developing pharmaceutical grade cannabidiol (CBD)† therapies in ...
Read More →
Revolutionizing Adult Epilepsy Treatment: Our Expanded Research Using Super SNEDDS Technology
November 8, 2024
In the evolving landscape of neurological disorders, epilepsy stands out as a complex challenge that affects millions of adults worldwide. The quest for more effective ...
Read More →
EmpowerPharm Inc. is delighted to announce the outcome of their Phase 2 clinical trial assessing Cannabidiol (CBD) drug product for Social Anxiety Disorder (SAD)
June 6, 2024
EmpowerPharm Inc. https://empowerpharm.ca/ is delighted to announce the outcome of their Phase 2 clinical trial assessing the dose finding, efficacy, safety, and tolerability of Cannabidiol ...
Read More →